Dr. Adriana Stoica

Dr. Adriana Stoica

Scientific Review Officer



Biography

Division:
Division of Basic and Integrative Biological Sciences DBIB
Review Branch:
Basic and Translational Cancer BTC
Study Section:
umor Evolution, Heterogeneity and Metastasis TEHM

Dr. Stoica received her Ph.D. degree in chemistry from the Lombardi Cancer Center at Georgetown University, Washington, D.C., studying the role of vitamin D3 and growth factors on estrogen receptor (ER) regulation in breast cancer. As a postdoctoral fellow, she extended her studies to the role of the heavy metal cadmium, as well as other endocrine disruptors  in the development of hormone-dependent cancers (breast and prostate). As an assistant professor, Dr. Stoica determined the cross talk between the phosphatidyl inositol 3-kinase (PI3-K)/the serine-threonine kinase Akt and ER signaling pathways in breast cancer. In addition to her 17 years of cancer research, Dr. Stoica also taught molecular biology, genetics in health and in disease, and biotechnology at the Health Studies Program of the School of Nursing at Georgetown. In 2008, Dr. Stoica moved to the National Cancer Institute as a scientific review officer and in 2025, she joined the Center for Scientific Review.

 

Last updated: 08/21/2025 05:05